Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Loose

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled annexin-V for monitoring treatment response in oncologyChristophe Van de Wiele, Hubert Vermeersch, David Loose, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2007
Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neckDavid Loose, Hubert Vermeersch, Filip De Vos, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neckDavid Loose, Alberto Signore, Elena Bonanno, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2007
(123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinomaDavid Loose, Alberto Signore, Ludovicus Staelens, et al.
Nuclear Medicine Communications|April 9, 2008
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neckFrancesco Cicone, David Loose, Philip Deron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2004
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinomaHubert Vermeersch, Kris Mervillie, Christophe Lahorte, et al.
Nuclear Medicine Communications|April 20, 2004
99mTc-HYNIC Annexin-V imaging of primary head and neck carcinomaHubert Vermeersch, David Loose, Christophe Lahorte, et al.
BMJ (Clinical Research Ed.)|June 10, 2022
Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysisRebecca J Williams, Heather D Dobbins, Tony Tse, et al.
Studies in Health Technology and Informatics|January 25, 2024
Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial WorkflowNhan V Do, Danne C Elbers, Nathanael R Fillmore, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled annexin-V for monitoring treatment response in oncologyChristophe Van de Wiele, Hubert Vermeersch, David Loose, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2007
Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neckDavid Loose, Hubert Vermeersch, Filip De Vos, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neckDavid Loose, Alberto Signore, Elena Bonanno, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2007
(123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinomaDavid Loose, Alberto Signore, Ludovicus Staelens, et al.
Nuclear Medicine Communications|April 9, 2008
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neckFrancesco Cicone, David Loose, Philip Deron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2004
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinomaHubert Vermeersch, Kris Mervillie, Christophe Lahorte, et al.
Nuclear Medicine Communications|April 20, 2004
99mTc-HYNIC Annexin-V imaging of primary head and neck carcinomaHubert Vermeersch, David Loose, Christophe Lahorte, et al.
BMJ (Clinical Research Ed.)|June 10, 2022
Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysisRebecca J Williams, Heather D Dobbins, Tony Tse, et al.
Studies in Health Technology and Informatics|January 25, 2024
Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial WorkflowNhan V Do, Danne C Elbers, Nathanael R Fillmore, et al.
Pageof 2